Inventor · disambiguated record
Mingyu Hu
Also filed as: HU MINGYU
4 granted patents·5 pending applications·4 citations·filing 2022–2025
65Inventor score
Files withGENEQUANTUM HEALTHCARE SUZHOU CO LTD9
Top patents by PatentIndex Score
9 records- 0191US11999748B2Exatecan derivatives, linker-payloads, and conjugates and thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Granted Jun 4, 2024·1 cites·17 claims
- 0290US11814394B2Exatecan derivatives, linker-payloads, and conjugates and thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Granted Nov 14, 2023·1 cites·7 claims
- 0387US11826432B2Linkers, conjugates and applications thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Granted Nov 28, 2023·2 cites·26 claims
- 0472US2025064957A1Exatecan derivatives, linker-payloads, and conjugates and thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 0570US12318457B2Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Granted Jun 3, 2025·0 cites·10 claims
- 0665US2025312477A1Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 0765US2024066141A1Linkers, conjugates and applications thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 0865US2025312476A1Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 0956US2025387505A1Anti-fgfr3 antibody conjugate and medical use thereofGENEQUANTUM HEALTHCARE SUZHOU CO LTD·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mingyu Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →